CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- 4 Open-market buy 10% owner bought 775,756 shares at $23.15 ($17,961,079)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 167 shares (grant or award)
- 4 Grant or award CHIEF LEGAL OFFICER acquired 167 shares (grant or award)
- 4 Grant or award VP, CFO acquired 167 shares (grant or award)
- 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
- 4 Open-market buy Director bought 200,000 shares at $0.18 ($35,740)
- 4 Open-market buy CHIEF LEGAL OFFICER bought 300,000 shares at $0.17 ($50,910)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 600,000 shares at $0.17 ($103,200)
- 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 5,000 shares (grant or award)
- 4 Open-market sale 10% owner sold 60,000 shares at $0.89 ($53,400)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 100,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 15 · 282 filings